Search results
Showing 1576 to 1590 of 1809 results for nice guidelines
This evidence summary has been updated and replaced by NICE guideline NG217.
Chronic obstructive pulmonary disease: aclidinium bromide (ESNM8)
This evidence summary has been updated and replaced by NICE guideline 115.
Chronic obstructive pulmonary disease: glycopyrronium bromide (ESNM9)
This evidence summary has been updated and replaced by NICE guideline 115.
Significant haemorrhage following trauma: tranexamic acid (ESUOM1)
This evidence summary has been updated and replaced by NICE guideline NG39.
This evidence summary has been updated and replaced by NICE guideline NG207.
Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)
This evidence summary has been updated and replaced by NICE guideline NG131.
This evidence summary has been updated and replaced by NICE guideline NG78.
Non-cystic fibrosis bronchiectasis: long-term azithromycin (ESUOM38)
This evidence summary has been updated and replaced by NICE guideline NG117.
This evidence summary has been updated and replaced by NICE guideline NG97.
Attention deficit hyperactivity disorder in children and young people: clonidine (ESUOM8)
This evidence summary has been updated and replaced by NICE guideline NG87.
Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates (ES15)
This evidence summary has been updated and replaced by NICE guideline NG101.
Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)
This evidence summary has been updated and replaced by NICE guideline 115.
Partial-onset seizures in epilepsy: zonisamide as monotherapy (ESNM17)
This evidence summary has been updated and replaced by NICE guideline NG217.
This evidence summary has been updated and replaced by NICE guideline NG87.
This evidence summary has been updated and replaced by NICE guideline NG28.